The role of endothelin in radiocontrast nephropathy

被引：11

作者：

Anarat A. ^{[1
]}

Duman N. ^{[1
]}

Noyan A. ^{[1
]}

Kibar M. ^{[2
]}

Anarat R. ^{[3
]}

机构：

[1] Department of Paediatric Nephrology, Çukurova University, School of Medicine, Adana

[2] Department of Nuclear Medicine, Çukurova University, School of Medicine, Adana

[3] Düzen Laboratories, Adana

来源：

International Urology and Nephrology | 1997年 / 29卷 / 5期

关键词：

International Urology; Nephrotoxicity; Diatrizoate; Radiocontrast Nephropathy; Radiocontrast Material;

D O I：

10.1007/BF02552209

中图分类号：

学科分类号：

摘要：

In the present study we investigated the role of endothelin and AT II in radio-contrast nephropathy induced in rats with reduced renal mass (70-75%). Thirty-five male Wistar albino rats weighing between 280 and 400 g were anaesthetized with ketamine (130 mg/kg b.w.) and right total, left 50% nephrectomy were performed. After this operation, the rats were kept under observation for six to eight weeks and then they were randomly separated into three groups. Group I rats were infused with 8.9 ml/kg (or 2.9 g of iodine/kg body weight) Na diatrizoate (Urovision, 1500 mosm/kg). Group II rats were infused with 0.9% NaCl in an equal volume with the radiocontrast material. Group III rats were given 4.5% NaCl that had the same volume and osmolality as the radiocontast material. Two hours after the drug infusions, blood and accumulated urine samples were collected from all the rats and tested for endothelin, AT II, BUN, creatinine, uric acid, electrolytes, calcium and phosphorus. We found that the plasma endothelin levels in Group I (77.64 ± 29.62 pg/ml) were significantly higher than in Group II (20.52 ± 5.83 pg/ml) and Group III (15.04 ± 5.15 pg/ml) (t = 8.34 and t = 9.14, respectively, p < 0.001). Therefore elevation in circulating endothelin might have been an additional factor leading to the radiocontrast-induced nephrotoxicity.

引用

页码：609 / 613

页数：4

共 17 条

[1]

Furchgott R.F., Zawadzki J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, (1980)

[2]

Hickey K.A., Rubayni G., Paul R.J., Highsmith R.F., Characterization of a coronary vasoconstriction produced by cultured endothelial cells, Am. J. Physiol., 248, (1985)

[3]

Palmer R.M.J., Ferrige A.G., Moncada S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, (1987)

[4]

Ignarro L.J., Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein, Circulat. Res., 65, (1989)

[5]

Yanagisawa M., Kunhara H., Mitsui Y., Yazaki Y., Goto K., Masaki T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, 332, (1988)

[6]

Kohan D.E., Endothelins in kidney: Physiology and pathophysiology, Am. J. Kidney Dis., 22, (1993)

[7]

Brown M., Chou S.Y., Porush J.G., Endothelins and kidney diseases, Nephron, 72, (1996)

[8]

Nord E.P., Renal actions of endothelin, Kidney Int., 44, (1993)

[9]

Heyman S.N., Brezis M., Reubinoff C.A., Greenfeld Z., Lechene C., Epstein F.H., Rosen S., Acute renal failure with selective medullary injury in the rat, J. Clin. Invest., 82, (1988)

[10]

Katzberg R.W., Morris T.W., Schulman G., Caldicott W.J.H., Boylan L.M., Foley M.J., Spataro R.F., Fisher E.W., Reactions to intravenous contrast media. Part II: Acute renal response in euvolemic and dehydrated dogs, Radiology, 147, (1983)

← 1 2 →